PATIENTS TREATED WITH INSULIN AND SULPHONYLUREA ARE AT INCREASED MORTALITY RISK AS COMPARED WITH THOSE TREATED WITH INSULIN PLUS METFORMIN

Lignende værker

• Cancer Specific Mortality in Insulin-Treated Type 2 Diabetes Patients
  af: Ioacara, Sorin, et al.
  Udgivet: (2014)
• Cardiovascular Mortality in Type 2 Diabetes Patients with Incident Exposure to Insulin Glargine
  af: Sorin Ioacara, et al.
  Udgivet: (2015-01-01)
• Cardiovascular Mortality in Type 2 Diabetes Patients with Incident Exposure to Insulin Glargine
  af: Ioacara, Sorin, et al.
  Udgivet: (2015)
• Progression to insulin therapy among patients with type 2 diabetes treated with sitagliptin or sulphonylurea plus metformin dual therapy
  af: Inzucchi, S. E., et al.
  Udgivet: (2015)
• First case of neonatal diabetes with KCNJ11 Q52R mutation successfully switched from insulin to sulphonylurea treatment
  af: Ioacara, Sorin, et al.
  Udgivet: (2017)